$0.00030
At close: Mar 24, 11:51 AM EDT
$0.00010
-0.00020-66.67%
After Hours: Mar 7, 4:11 PM EDT
Comments
Loading...
Scopus BioPharma Analyst Ratings and Price Targets | OTC:SCPS | Benzinga
Scopus BioPharma Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Scopus BioPharma Corp from these most-recent analyst ratings.
Analyst Ratings for Scopus BioPharma
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Scopus BioPharma (SCPS) stock?
There is no price target for Scopus BioPharma
What is the most recent analyst rating for Scopus BioPharma (SCPS)?
There is no analyst for Scopus BioPharma
When was the last upgrade for Scopus BioPharma (SCPS)?
There is no last upgrade for Scopus BioPharma
When was the last downgrade for Scopus BioPharma (SCPS)?
There is no last downgrade for Scopus BioPharma.
When is the next analyst rating going to be posted or updated for Scopus BioPharma (SCPS)?
There is no next analyst rating for Scopus BioPharma.
Is the Analyst Rating Scopus BioPharma (SCPS) correct?
There is no next analyst rating for Scopus BioPharma.
Browse analyst ratings and price targets on all stocks.